Cytek Investor Day Presentation Deck
Note: Fiscal Quarter
Non-GAAP Adjusted EBITDA
($ in thousands)
Non-GAAP Adjusted EBITDA Reconciliation
($ in thousands)
Net Income
Adjustments
Depreciation and Amortization
Provision for (Benefits from) Income Tax
Interest Income
Interest Expense
Foreign currency exchange loss (gain), ne
Litigation Settlement
Loss on Lease Exit Cost
Acqisition Related Expenses
Stock-Based Compensation Expense
Adjusted EBITDA
Revenue
Adjusted EBITDA % of Revenue
FY19A
(16,827)
309
534
(711)
1
(32)
20,019
269
3,561
57,883
6%
FY20A
19,411
578
(4,982)
(110)
333
(463)
611
15,379
92,839
17%
FY21A
3,027
1,241
2,921
(49)
1,741
1,481
6,586
17,525
127,950
14%
1Q2020
(839)
105
198
(86)
O
104
105
(411)
17,988
-2%
2Q2020
8,111
161
(7,914)
(15)
1
(79)
109
373
19,137
2%
3Q2020
6,539
179
387
(3)
2
(137)
125
7,091
25,095
28%
4Q2020
5,600
133
2,348
(5)
330
(350)
347
229
271
8,327
30,619
27%
1
1Q2021
101
169
50
(10)
375
663
456
1,804
24,272
7%
2Q2021
2,671
194
597
(9)
433
135
667
4,688
30,408
15%
3Q2021
1,420
194
655
(12)
442
388
2,455
5,542
34,376
16%
4Q2021
(1,165)
685
1,619
(19)
492
295
347
229
3,008
5,491
38,893
14%
1Q2022
(2,158)
1,470
(1,144)
(18)
590
422
3,837
2,998
35,064
7%
CYTEK
TRANSCEND THE CONVENTIONAL
123View entire presentation